Extended Data Fig. 1: Risk of incident post-acute sequelae in COVID-19.
From: High-dimensional characterization of post-acute sequelae of COVID-19
a–c, Incident diagnoses (a), incident medication use (b) and incident laboratory abnormalities (c). All VHA users served as the referent category. Outcomes were ascertained from day 30 after COVID-19 diagnosis until the end of follow-up. Adjusted hazard ratios for incident sequelae that are larger than 1 and P value less than 6.57 × 10−5 are presented. Hazard ratios (dots) and 95% confidence intervals (bars) are presented on log10 scale.
